Gaballa 2015.

Trial name or title	Feasibility and functional outcome of laparoscopic nerve sparing radical hysterectomy (NCT02524756)
Methods	Study type: interventional study Study design: phase III randomised controlled trial Intervention model: parallel assignment Masking: no masking Primary purpose: treatment outcome measures
Participants	Participants’ characteristics: women aged 18 years or over Inclusion criteria Age > 18 years Karnofsky > 80, or American Society of Anaethesiology (ASA) I‐II Stage IA2‐IB1‐IB2‐IIA1‐IIA2‐IIB cervical cancer according to FIGO (International Federation of Gynecology and Obstetrics) staging Stage II endometrial cancer Exclusion criteria Non‐invasive cancer Pregnancy Bladder dysfunction detected prior to surgery Previous pelvic lymphadenectomy Tumour recurrence Incomplete surgery, unresectable lesion
Interventions	Intervention: laparoscopic nerve‐sparing radical hysterectomy (type III/C1) Control: laparoscopic radical hysterectomy (type III/C2).
Outcomes	Primary outcome measures: duration of postoperative catheterisation until PVR urine volume is less than 100 mL Secondary outcome measures: intraoperative complications, amount of blood intraoperative blood loss, operative time, occurrence of early postoperative complication within 30 days of operation, occurrence of late complications related to surgery more than 30 days postoperative Removal of urinary catheter on the third day postoperative without prior bladder training exercise and measurement of PVR
Starting date	November 2014
Contact information	Principal Investigator: Khaled Gaballa, Assistant Lecturer of surgical oncology, Mansoura Universitry Study Chair: Adel Taha Denewar, MD, Ph.D, Head of surgical oncology department, Mansoura oncology centre, Mansoura University Study Director: Giovanni Scambia, MD,Ph.D, Head of the Department for Woman and Unborn Life Health Care‐ Catholic University of the Sacred Heart‐ Rome, Italy
Notes	ClinicalTrials.gov Identifier: NCT02524756

PVR: postvoid residual urine volume